Artia Global Partners’s Insmed INSM Stock Holding History

Artia Global Partners’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$103M	Sell	628,712 -53,500	-8%	-$8.23M	20.59%	1
2025 Q4	$119M	Sell	682,212 -50,000	-7%	-$9.12M	16.82%	1
2025 Q3	$105M	Sell	732,212 -20,500	-3%	-$2.51M	16.71%	1
2025 Q2	$75.8M	Buy	752,712 +434,473	+137%	+$33.2M	18.23%	2
2025 Q1	$24.3M	Buy	318,239 +150,300	+89%	+$11.5M	6.15%	6
2024 Q4	$11.6M	Buy	167,939 +115,000	+217%	+$8.28M	4.14%	13
2024 Q3	$3.86M	Sell	52,939 -497	-0.9%	-$36.7K	1.05%	19
2024 Q2	$3.58M	Sell	53,436 -64,800	-55%	-$2.51M	0.69%	21
2024 Q1	$3.21M	Buy	118,236 +43,300	+58%	+$1.21M	0.64%	21
2023 Q4	$2.32M	Buy	+74,936	New	+$1.94M	0.68%	19

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Artia Global Partners's INSM Position: Q1 2026 in Review

Artia Global Partners reduced its Insmed (INSM) stake by 7.8% in Q1 2026, selling an estimated $8.23M and leaving 628,712 shares worth $103M. The position accounts for 20.59% of the portfolio, ranked #1.

Artia Global Partners first reported a position in INSM in Q4 2023 and has held it in 10 quarters since. The position peaked at $119M in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

Artia Global Partners held 628,712 shares of Insmed worth $103M as of Q1 2026.
Artia Global Partners sold 53,500 Insmed shares in Q1 2026, an estimated $8.23M.
Insmed made up 20.59% of Artia Global Partners's portfolio in Q1 2026, its #1 holding.
Artia Global Partners first reported a position in Insmed in Q4 2023 and has held it in 10 quarters since.
Artia Global Partners's Insmed position peaked at $119M in Q4 2025.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Artia Global Partners's 13F filing for Q1 2026, filed 15 May 2026.